Why Diabetes Care Must Look Beyond Symptoms

A prescription should not be the end of the conversation

When a person is told that blood glucose, blood pressure, or cholesterol is elevated, the usual response is often a prescription. Medication can be appropriate and sometimes essential. But a prescription does not explain why the problem developed, what may be keeping it active, or what else the person needs in order to become healthier.

That is the central concern raised in the recent Mercola article. Its argument is that modern care can become too focused on managing measurable symptoms while giving too little attention to food, movement, sleep, stress, environmental pressures, medication burden, and the deeper metabolic conditions that influence chronic disease.

This concern aligns with the Diabetes Reversal Group approach. Type 2 diabetes should not be reduced to a glucose number, and care should not be reduced to a medication list. A person deserves an evaluation of the full picture and a plan that addresses both immediate risk and the factors that may be driving long-term metabolic dysfunction.

High glucose is a signal—and a source of harm

Looking beyond symptoms does not mean ignoring the symptoms. High glucose is not merely an inconvenient number. Persistent hyperglycemia can damage blood vessels, nerves, eyes, kidneys, and other tissues. High blood pressure and abnormal cholesterol can increase cardiovascular and kidney risk even when a person feels well.

This creates two responsibilities. The first is to reduce harmful levels of glucose and other risk factors. The second is to understand why those levels are elevated and what can be changed.

Medication may help with the first responsibility. Food quality, meal timing, movement, sleep, stress, body composition, alcohol use, other medications, and social conditions may influence the second. These factors overlap, but one does not replace the others.

The American Diabetes Association’s 2026 comprehensive-evaluation guidance supports a broad assessment that includes complications, psychosocial health, lifestyle, social determinants, medications, and personal goals. That kind of assessment is consistent with root-cause care because it asks what is happening in the person’s life and body—not only what number needs to be lowered.

Why medication alone is not enough

Diabetes medicines can lower glucose and reduce risk. They may improve insulin sensitivity, replace insulin the body cannot produce, increase insulin release when appropriate, reduce glucose absorption, or act through the gut and kidneys. Some medications also reduce cardiovascular or kidney events in selected patients.

Those benefits matter. But medication alone cannot make food affordable, restore sleep, resolve chronic stress, create a safe place to exercise, repair social connection, or teach a person how to build sustainable routines. It can manage an important part of the disease while leaving the root cause untouched.

The ADA’s 2026 pharmacologic guidance recommends person-centered treatment that considers glucose goals, cardiovascular and kidney risk, weight, hypoglycemia, adverse effects, cost, access, treatment burden, tolerability, and personal preferences. That supports a broader interpretation of medication: it is one tool within an individualized plan, not the entire plan.

Some treatments may be continued for years because the underlying risk remains. That does not prove that they are curing the root cause. It also does not mean they are useless. It means the clinician and patient should continue asking whether the expected benefit remains greater than the burden and how lifestyle and metabolic improvements may change the treatment plan over time.

Medication review is part of root-cause care

Whole-person care includes regular medication review. People can accumulate prescriptions as new symptoms and diagnoses appear. A medicine that was appropriate at one stage may later cause side effects, interact with another treatment, become unaffordable, or no longer match the person’s goals.

A thoughtful review asks: What is this medicine intended to do? What benefit should we expect? What side effects matter? Is the dose still appropriate for kidney function and age? Is there a lower-cost option? Can food, movement, sleep, or stress support reduce the need for some treatment over time? What monitoring is needed before making a change?

The outcome of a review may be a dose reduction, a switch, discontinuation, or continuation because the benefit remains important. Root-cause care does not assume that every prescription should be stopped. It also does not assume that every prescription should continue forever without reassessment.

Insulin deserves particular care. It may be essential when the body cannot produce enough insulin, and stopping it without supervision can be dangerous. Statins, blood-pressure medications, SGLT2 inhibitors, and other therapies may reduce risks that a person cannot feel. A person should never treat the absence of symptoms as proof that a medicine is unnecessary.

Remission is possible

The international consensus report on type 2 diabetes remission recommends the term remission rather than cure or reversal. It defines remission as an HbA1c below 6.5% for at least three months without glucose-lowering medication, with continued monitoring because diabetes can return.

At Diabetes Reversal Group, we believe type 2 diabetes care should look beyond symptom control and beyond a single prescription. Food, movement, sleep, stress support, relationships, access to care, clinical monitoring all belong in the same plan.

By: Dr. Jeffrey Hockings, CEO / Founder & Kristine Burke, MD, Chief Medical Officer

This article is educational and does not replace individualized medical advice. Do not start, stop, reduce, or change insulin, statins, diabetes medication, or any other prescription without guidance from the clinician managing your care.